Grant: Engage Plus Grants Program
University of Ottawa
$12,500.00
Phase 2- A collaboration between the University of Ottawa and Vivosonic towards the use of the Integrity V500 in the quantitative evaluation of tinnitus
FY 2018-19
Summary
Tinnitus is a life-altering condition that affects 360,000 Canadians and represents an economic burden of*hundreds of millions to the Canadian economy. While subjective tools are currently used to diagnose the*condition, no reliable clinical objective measure exists. The purpose of this Engage Plus is to develop the*hardware, algorithms and testing protocol required to discriminate tinnitus from the normal hearing population*with our partner, Vivosonic Inc. Our success will lead to an innovative clinical measurement tool.*Our research team has developed an innovative gap-in-noise technique that could theoretically be applied to*humans for tinnitus detection. Vivosonic Inc manufacturers the Integrity(TM) V500 system which records*electrical responses from the auditory nerve to the brainstem, known as the auditory brainstem response (ABR).*Their technology is unique on the market as it uses a patented algorithm, pre-filter, onsite amplification, and a*digital transmission that, together, minimize the level of noise captured in the recording. In our Phase-1 Engage*we created a prototype and temporal processing test that was piloted on a normal population. We confirmed*that their platform is ideal for application of our gap-in-noise protocol and capturing small ABR changes under*noisy (clinically relevant) conditions. These two factors are critical for developing a clinically viable*measurement system.*In this Engage Plus our goal is to introduce modifications to the hardware, temporal analysis and collection*protocol required to classify the tinnitus population. We will use a noise stimulus with small silent intervals of*altering durations to measure the response of the auditory nerve, modifying stimulus frequency and gap width*ranges during the protocol. The modified system will extract our novel ABR measures, these will be treated*with Vivosonic's proprietary signal conditioning and machine learning based classification approach to...
Program
Engage Plus Grants Program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
529586-2018
Name nom
Benoit, Daniel
Department département
Rehabilitation Sciences, School of
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
12500
Program id
EGP2
Program name en
Engage Plus Grants Program
Program name fr
Programme de subvention d'engagement partenarial Plus
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
9000
Research subject group en
Medical sciences
Research subject group fr
Sciences médicales
Research subject en
Medical sciences
Research subject fr
Sciences médicales
Partie
1
Nb partie
1
Application title
Phase 2- A collaboration between the University of Ottawa and Vivosonic towards the use of the Integrity V500 in the quantitative evaluation of tinnitus
Keyword
NSERC
Application summary
Tinnitus is a life-altering condition that affects 360,000 Canadians and represents an economic burden of*hundreds of millions to the Canadian economy. While subjective tools are currently used to diagnose the*condition, no reliable clinical objective measure exists. The purpose of this Engage Plus is to develop the*hardware, algorithms and testing protocol required to discriminate tinnitus from the normal hearing population*with our partner, Vivosonic Inc. Our success will lead to an innovative clinical measurement tool.*Our research team has developed an innovative gap-in-noise technique that could theoretically be applied to*humans for tinnitus detection. Vivosonic Inc manufacturers the Integrity(TM) V500 system which records*electrical responses from the auditory nerve to the brainstem, known as the auditory brainstem response (ABR).*Their technology is unique on the market as it uses a patented algorithm, pre-filter, onsite amplification, and a*digital transmission that, together, minimize the level of noise captured in the recording. In our Phase-1 Engage*we created a prototype and temporal processing test that was piloted on a normal population. We confirmed*that their platform is ideal for application of our gap-in-noise protocol and capturing small ABR changes under*noisy (clinically relevant) conditions. These two factors are critical for developing a clinically viable*measurement system.*In this Engage Plus our goal is to introduce modifications to the hardware, temporal analysis and collection*protocol required to classify the tinnitus population. We will use a noise stimulus with small silent intervals of*altering durations to measure the response of the auditory nerve, modifying stimulus frequency and gap width*ranges during the protocol. The modified system will extract our novel ABR measures, these will be treated*with Vivosonic's proprietary signal conditioning and machine learning based classification approach to...